FMR LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$169,317
-25.0%
64,379
+0.7%
0.00%
Q2 2023$225,631
-42.9%
63,918
-50.0%
0.00%
Q1 2023$395,032
+46.1%
127,842
+100.0%
0.00%
Q4 2022$270,335
+77.9%
63,909
-0.6%
0.00%
Q3 2022$152,000
-17.4%
64,311
-0.7%
0.00%
Q2 2022$184,000
-1.1%
64,745
+0.1%
0.00%
Q1 2022$186,000
+44.2%
64,692
+406.7%
0.00%
Q3 2020$129,000
-75.0%
12,768
-74.1%
0.00%
Q2 2020$515,000
-50.3%
49,368
-59.8%
0.00%
Q1 2020$1,037,000
-3.5%
122,8680.0%0.00%
Q4 2019$1,075,000
-53.4%
122,868
-42.7%
0.00%
Q3 2019$2,309,000
-37.1%
214,568
-25.7%
0.00%
Q2 2019$3,670,000
-82.0%
288,781
-45.2%
0.00%
-100.0%
Q1 2019$20,445,000
+16.8%
527,068
-38.7%
0.00%0.0%
Q4 2018$17,507,000
-72.4%
860,266
-37.7%
0.00%
-71.4%
Q3 2018$63,360,000
-37.7%
1,381,893
-19.7%
0.01%
-41.7%
Q2 2018$101,756,000
-5.8%
1,720,294
+8.3%
0.01%
-7.7%
Q1 2018$108,069,000
-36.0%
1,588,089
-7.0%
0.01%
-35.0%
Q4 2017$168,851,000
-33.3%
1,708,154
-19.2%
0.02%
-35.5%
Q3 2017$253,148,000
+14.9%
2,113,970
-16.1%
0.03%
+14.8%
Q2 2017$220,252,000
+67.2%
2,520,048
-28.8%
0.03%
+58.8%
Q1 2017$131,715,000
+24.0%
3,540,729
+2.4%
0.02%
+21.4%
Q4 2016$106,201,000
-67.5%
3,459,319
-29.0%
0.01%
-68.2%
Q3 2016$326,799,000
+125.1%
4,873,9630.0%0.04%
+120.0%
Q2 2016$145,195,000
+1.4%
4,873,963
+0.0%
0.02%0.0%
Q1 2016$143,121,000
-62.5%
4,873,026
+0.2%
0.02%
-60.8%
Q4 2015$381,444,000
+4.4%
4,865,362
+0.4%
0.05%
-1.9%
Q3 2015$365,238,000
-35.1%
4,846,573
+0.5%
0.05%
-27.8%
Q2 2015$563,041,000
-40.8%
4,822,624
+19.8%
0.07%
-40.5%
Q1 2015$950,532,000
+24.4%
4,025,798
-0.2%
0.12%
+22.2%
Q4 2014$763,787,000
+14.8%
4,035,436
+44.7%
0.10%
+10.0%
Q3 2014$665,494,000
+564.0%
2,789,515
+83.7%
0.09%
+592.3%
Q2 2014$100,229,000
-58.0%
1,518,618
-33.8%
0.01%
-60.6%
Q1 2014$238,802,000
-19.6%
2,293,085
-20.0%
0.03%
-21.4%
Q4 2013$296,885,000
+53.8%
2,867,623
-20.3%
0.04%
+40.0%
Q3 2013$193,014,000
+20.4%
3,596,997
-0.4%
0.03%
+15.4%
Q2 2013$160,255,0003,611,7970.03%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$12,636,0002.61%
AIGH Capital Management LLC 964,590$9,376,0001.97%
Worth Venture Partners, LLC 226,758$2,204,0001.07%
Camber Capital Management LP 2,555,000$24,835,0000.85%
Palo Alto Investors LP 1,392,997$13,540,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,769,795$36,642,0000.77%
GLOBEFLEX CAPITAL L P 428,680$4,167,0000.76%
Zebra Capital Management LLC 34,243$333,0000.37%
Sofinnova Investments, Inc. 344,917$3,353,0000.20%
RICE HALL JAMES & ASSOCIATES, LLC 605,792$5,888,0000.19%
View complete list of PUMA BIOTECHNOLOGY INC shareholders